These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Indications for the use of neuleptil. Review of the literature and clinical contribution]. Catalano A, Del Pistoia L, De Risio C, Ridolo P. Riv Sper Freniatr Med Leg Alien Ment; 1967; 91():Suppl 5:1307+. PubMed ID: 4388059 [No Abstract] [Full Text] [Related]
12. [On the position of butyrophenone derivative Triperidol in psychiatric treatment]. Lange E, Scholz V. Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875 [No Abstract] [Full Text] [Related]
13. Comparative trial of low dose haloperidol and fluphenazine in office patients. Ayd FJ. Dis Nerv Syst; 1972 Mar; 33(3):192-5. PubMed ID: 5022455 [No Abstract] [Full Text] [Related]
14. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients. Villeneuve C, Ananth JV, Ban TA, Lehmann HE. Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943 [No Abstract] [Full Text] [Related]